Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Epidermal growth factor receptor (EGFR) has been shown to be over-expressed in TNBC and represents a rational treatment target. METHODS: We examined single agent and combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonici, Alexandra, Browne, Alacoque L., Ibrahim, Mohamed F. K., Fanning, Kevin P., Roche, Sandra, Conlon, Neil T., O’Neill, Fiona, Meiller, Justine, Cremona, Mattia, Morgan, Clare, Hennessy, Bryan T., Eustace, Alex J., Solca, Flavio, O’Donovan, Norma, Crown, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
TNBC in 2019: Promising Signals for the Treatment of a Formidable Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987485/
https://www.ncbi.nlm.nih.gov/pubmed/32064003
http://dx.doi.org/10.1177/1758835919897546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987485/
https://www.ncbi.nlm.nih.gov/pubmed/32064003
http://dx.doi.org/10.1177/1758835919897546

Ejemplares similares